Lilly, the company that makes brand name Humalog insulin, announced they would be producing an authorized generic of Humalog, Insulin Lispro, the day they testified before Congress this spring.
However, Lilly has put it out to PBMs as a ‘brand (name) alternative’, not a direct generic of Humalog; it is not being listed on formularies as a generic, which means patients cannot benefit from generic pricing.
On my plan, Insulin Lispro is listed as ‘non-formulary, brand name’, and is actually MORE expensive than brand name Humalog.
My PBM says there isn’t anything they can do because it’s been given to them as a brand name alternative to Humalog, NOT as a generic.
I’m trying to raise awareness of this deception on Lilly’s behalf and make this insulin available, as it was promised to Congress, to everyone for a generic copay. I’ve started a social media campaign and posted all this info on Twitter if anyone wants to help (my twitter handle is the same as my username here!)